Pulse Biosciences, Inc. PLSE Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s financing cash flow?
- Pulse Biosciences, Inc. (PLSE) reported financing cash flow of $2.21M in Q1 2026.
- How has Pulse Biosciences, Inc.'s financing cash flow changed year-over-year?
- Pulse Biosciences, Inc.'s financing cash flow decreased by 85.1% year-over-year, from $14.81M to $2.21M.
- What is the long-term trend for Pulse Biosciences, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s financing cash flow has grown at a -27.8% compound annual growth rate (CAGR), from $63.23M to $17.15M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.